世界のRNA標的小分子市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global RNA-Targeted Small Molecules Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-5997
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、105ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、RNA標的小分子の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（mRNA翻訳調節、RNAスプライシング修飾、直接RNAターゲティング、間接RNAターゲティング-エピトランスクリプトミクス）、用途別市場規模（病院、研究所、薬局）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・RNA標的小分子の市場動向
・企業の競争状況、市場シェア
・RNA標的小分子の種類別市場規模と予測2016-2027（mRNA翻訳調節、RNAスプライシング修飾、直接RNAターゲティング、間接RNAターゲティング-エピトランスクリプトミクス）
・RNA標的小分子の用途別市場規模と予測2016-2027（病院、研究所、薬局）
・RNA標的小分子の北米市場規模2016-2027（アメリカ、カナダ）
・RNA標的小分子の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・RNA標的小分子のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・RNA標的小分子の中南米市場規模2016-2027（メキシコ、ブラジル）
・RNA標的小分子の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Accent Therapeutics、Anima Biotech Inc.、Arrakis Pharmaceuticals、Epics Therapeutics、Expansion Therapeutics、Gotham Therapeutics、H3 Biomedicine、Ribometrix、Skyhawk Therapeutics、STORM Therapeutics、Twentyeight-Seven Therapeutics）
・結論

RNA-targeting small molecules represent a class of small molecules.
RNA-targeting small molecules represent a class of small molecules, organic compounds with traditional drug properties that can bind to RNA secondary or tertiary structures and alter translation patterns, localization, and degradation.

Market Analysis and Insights: Global RNA-Targeted Small Molecules Market
The global RNA-Targeted Small Molecules market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global RNA-Targeted Small Molecules market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global RNA-Targeted Small Molecules market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global RNA-Targeted Small Molecules market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global RNA-Targeted Small Molecules market.

Global RNA-Targeted Small Molecules Scope and Market Size
RNA-Targeted Small Molecules market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global RNA-Targeted Small Molecules market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
mRNA Translation Regulation
RNA Splicing Modification
Direct RNA Targeting
Indirect RNA Targeting – Epitranscriptomics

Segment by Application
Hospitals
Laboratories
Phamacy

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Accent Therapeutics
Anima Biotech Inc.
Arrakis Pharmaceuticals
Epics Therapeutics
Expansion Therapeutics
Gotham Therapeutics
H3 Biomedicine
Ribometrix
Skyhawk Therapeutics
STORM Therapeutics
Twentyeight-Seven Therapeutics

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global RNA-Targeted Small Molecules Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 mRNA Translation Regulation
1.2.3 RNA Splicing Modification
1.2.4 Direct RNA Targeting
1.2.5 Indirect RNA Targeting – Epitranscriptomics
1.3 Market by Application
1.3.1 Global RNA-Targeted Small Molecules Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Laboratories
1.3.4 Phamacy
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global RNA-Targeted Small Molecules Market Perspective (2016-2027)
2.2 RNA-Targeted Small Molecules Growth Trends by Regions
2.2.1 RNA-Targeted Small Molecules Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 RNA-Targeted Small Molecules Historic Market Share by Regions (2016-2021)
2.2.3 RNA-Targeted Small Molecules Forecasted Market Size by Regions (2022-2027)
2.3 RNA-Targeted Small Molecules Industry Dynamic
2.3.1 RNA-Targeted Small Molecules Market Trends
2.3.2 RNA-Targeted Small Molecules Market Drivers
2.3.3 RNA-Targeted Small Molecules Market Challenges
2.3.4 RNA-Targeted Small Molecules Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top RNA-Targeted Small Molecules Players by Revenue
3.1.1 Global Top RNA-Targeted Small Molecules Players by Revenue (2016-2021)
3.1.2 Global RNA-Targeted Small Molecules Revenue Market Share by Players (2016-2021)
3.2 Global RNA-Targeted Small Molecules Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by RNA-Targeted Small Molecules Revenue
3.4 Global RNA-Targeted Small Molecules Market Concentration Ratio
3.4.1 Global RNA-Targeted Small Molecules Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by RNA-Targeted Small Molecules Revenue in 2020
3.5 RNA-Targeted Small Molecules Key Players Head office and Area Served
3.6 Key Players RNA-Targeted Small Molecules Product Solution and Service
3.7 Date of Enter into RNA-Targeted Small Molecules Market
3.8 Mergers & Acquisitions, Expansion Plans

4 RNA-Targeted Small Molecules Breakdown Data by Type
4.1 Global RNA-Targeted Small Molecules Historic Market Size by Type (2016-2021)
4.2 Global RNA-Targeted Small Molecules Forecasted Market Size by Type (2022-2027)

5 RNA-Targeted Small Molecules Breakdown Data by Application
5.1 Global RNA-Targeted Small Molecules Historic Market Size by Application (2016-2021)
5.2 Global RNA-Targeted Small Molecules Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America RNA-Targeted Small Molecules Market Size (2016-2027)
6.2 North America RNA-Targeted Small Molecules Market Size by Type
6.2.1 North America RNA-Targeted Small Molecules Market Size by Type (2016-2021)
6.2.2 North America RNA-Targeted Small Molecules Market Size by Type (2022-2027)
6.2.3 North America RNA-Targeted Small Molecules Market Size by Type (2016-2027)
6.3 North America RNA-Targeted Small Molecules Market Size by Application
6.3.1 North America RNA-Targeted Small Molecules Market Size by Application (2016-2021)
6.3.2 North America RNA-Targeted Small Molecules Market Size by Application (2022-2027)
6.3.3 North America RNA-Targeted Small Molecules Market Size by Application (2016-2027)
6.4 North America RNA-Targeted Small Molecules Market Size by Country
6.4.1 North America RNA-Targeted Small Molecules Market Size by Country (2016-2021)
6.4.2 North America RNA-Targeted Small Molecules Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe RNA-Targeted Small Molecules Market Size (2016-2027)
7.2 Europe RNA-Targeted Small Molecules Market Size by Type
7.2.1 Europe RNA-Targeted Small Molecules Market Size by Type (2016-2021)
7.2.2 Europe RNA-Targeted Small Molecules Market Size by Type (2022-2027)
7.2.3 Europe RNA-Targeted Small Molecules Market Size by Type (2016-2027)
7.3 Europe RNA-Targeted Small Molecules Market Size by Application
7.3.1 Europe RNA-Targeted Small Molecules Market Size by Application (2016-2021)
7.3.2 Europe RNA-Targeted Small Molecules Market Size by Application (2022-2027)
7.3.3 Europe RNA-Targeted Small Molecules Market Size by Application (2016-2027)
7.4 Europe RNA-Targeted Small Molecules Market Size by Country
7.4.1 Europe RNA-Targeted Small Molecules Market Size by Country (2016-2021)
7.4.2 Europe RNA-Targeted Small Molecules Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific RNA-Targeted Small Molecules Market Size (2016-2027)
8.2 Asia-Pacific RNA-Targeted Small Molecules Market Size by Type
8.2.1 Asia-Pacific RNA-Targeted Small Molecules Market Size by Type (2016-2021)
8.2.2 Asia-Pacific RNA-Targeted Small Molecules Market Size by Type (2022-2027)
8.2.3 Asia-Pacific RNA-Targeted Small Molecules Market Size by Type (2016-2027)
8.3 Asia-Pacific RNA-Targeted Small Molecules Market Size by Application
8.3.1 Asia-Pacific RNA-Targeted Small Molecules Market Size by Application (2016-2021)
8.3.2 Asia-Pacific RNA-Targeted Small Molecules Market Size by Application (2022-2027)
8.3.3 Asia-Pacific RNA-Targeted Small Molecules Market Size by Application (2016-2027)
8.4 Asia-Pacific RNA-Targeted Small Molecules Market Size by Region
8.4.1 Asia-Pacific RNA-Targeted Small Molecules Market Size by Region (2016-2021)
8.4.2 Asia-Pacific RNA-Targeted Small Molecules Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America RNA-Targeted Small Molecules Market Size (2016-2027)
9.2 Latin America RNA-Targeted Small Molecules Market Size by Type
9.2.1 Latin America RNA-Targeted Small Molecules Market Size by Type (2016-2021)
9.2.2 Latin America RNA-Targeted Small Molecules Market Size by Type (2022-2027)
9.2.3 Latin America RNA-Targeted Small Molecules Market Size by Type (2016-2027)
9.3 Latin America RNA-Targeted Small Molecules Market Size by Application
9.3.1 Latin America RNA-Targeted Small Molecules Market Size by Application (2016-2021)
9.3.2 Latin America RNA-Targeted Small Molecules Market Size by Application (2022-2027)
9.3.3 Latin America RNA-Targeted Small Molecules Market Size by Application (2016-2027)
9.4 Latin America RNA-Targeted Small Molecules Market Size by Country
9.4.1 Latin America RNA-Targeted Small Molecules Market Size by Country (2016-2021)
9.4.2 Latin America RNA-Targeted Small Molecules Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa RNA-Targeted Small Molecules Market Size (2016-2027)
10.2 Middle East & Africa RNA-Targeted Small Molecules Market Size by Type
10.2.1 Middle East & Africa RNA-Targeted Small Molecules Market Size by Type (2016-2021)
10.2.2 Middle East & Africa RNA-Targeted Small Molecules Market Size by Type (2022-2027)
10.2.3 Middle East & Africa RNA-Targeted Small Molecules Market Size by Type (2016-2027)
10.3 Middle East & Africa RNA-Targeted Small Molecules Market Size by Application
10.3.1 Middle East & Africa RNA-Targeted Small Molecules Market Size by Application (2016-2021)
10.3.2 Middle East & Africa RNA-Targeted Small Molecules Market Size by Application (2022-2027)
10.3.3 Middle East & Africa RNA-Targeted Small Molecules Market Size by Application (2016-2027)
10.4 Middle East & Africa RNA-Targeted Small Molecules Market Size by Country
10.4.1 Middle East & Africa RNA-Targeted Small Molecules Market Size by Country (2016-2021)
10.4.2 Middle East & Africa RNA-Targeted Small Molecules Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Accent Therapeutics
11.1.1 Accent Therapeutics Company Details
11.1.2 Accent Therapeutics Business Overview
11.1.3 Accent Therapeutics RNA-Targeted Small Molecules Introduction
11.1.4 Accent Therapeutics Revenue in RNA-Targeted Small Molecules Business (2016-2021)
11.1.5 Accent Therapeutics Recent Development
11.2 Anima Biotech Inc.
11.2.1 Anima Biotech Inc. Company Details
11.2.2 Anima Biotech Inc. Business Overview
11.2.3 Anima Biotech Inc. RNA-Targeted Small Molecules Introduction
11.2.4 Anima Biotech Inc. Revenue in RNA-Targeted Small Molecules Business (2016-2021)
11.2.5 Anima Biotech Inc. Recent Development
11.3 Arrakis Pharmaceuticals
11.3.1 Arrakis Pharmaceuticals Company Details
11.3.2 Arrakis Pharmaceuticals Business Overview
11.3.3 Arrakis Pharmaceuticals RNA-Targeted Small Molecules Introduction
11.3.4 Arrakis Pharmaceuticals Revenue in RNA-Targeted Small Molecules Business (2016-2021)
11.3.5 Arrakis Pharmaceuticals Recent Development
11.4 Epics Therapeutics
11.4.1 Epics Therapeutics Company Details
11.4.2 Epics Therapeutics Business Overview
11.4.3 Epics Therapeutics RNA-Targeted Small Molecules Introduction
11.4.4 Epics Therapeutics Revenue in RNA-Targeted Small Molecules Business (2016-2021)
11.4.5 Epics Therapeutics Recent Development
11.5 Expansion Therapeutics
11.5.1 Expansion Therapeutics Company Details
11.5.2 Expansion Therapeutics Business Overview
11.5.3 Expansion Therapeutics RNA-Targeted Small Molecules Introduction
11.5.4 Expansion Therapeutics Revenue in RNA-Targeted Small Molecules Business (2016-2021)
11.5.5 Expansion Therapeutics Recent Development
11.6 Gotham Therapeutics
11.6.1 Gotham Therapeutics Company Details
11.6.2 Gotham Therapeutics Business Overview
11.6.3 Gotham Therapeutics RNA-Targeted Small Molecules Introduction
11.6.4 Gotham Therapeutics Revenue in RNA-Targeted Small Molecules Business (2016-2021)
11.6.5 Gotham Therapeutics Recent Development
11.7 H3 Biomedicine
11.7.1 H3 Biomedicine Company Details
11.7.2 H3 Biomedicine Business Overview
11.7.3 H3 Biomedicine RNA-Targeted Small Molecules Introduction
11.7.4 H3 Biomedicine Revenue in RNA-Targeted Small Molecules Business (2016-2021)
11.7.5 H3 Biomedicine Recent Development
11.8 Ribometrix
11.8.1 Ribometrix Company Details
11.8.2 Ribometrix Business Overview
11.8.3 Ribometrix RNA-Targeted Small Molecules Introduction
11.8.4 Ribometrix Revenue in RNA-Targeted Small Molecules Business (2016-2021)
11.8.5 Ribometrix Recent Development
11.9 Skyhawk Therapeutics
11.9.1 Skyhawk Therapeutics Company Details
11.9.2 Skyhawk Therapeutics Business Overview
11.9.3 Skyhawk Therapeutics RNA-Targeted Small Molecules Introduction
11.9.4 Skyhawk Therapeutics Revenue in RNA-Targeted Small Molecules Business (2016-2021)
11.9.5 Skyhawk Therapeutics Recent Development
11.10 STORM Therapeutics
11.10.1 STORM Therapeutics Company Details
11.10.2 STORM Therapeutics Business Overview
11.10.3 STORM Therapeutics RNA-Targeted Small Molecules Introduction
11.10.4 STORM Therapeutics Revenue in RNA-Targeted Small Molecules Business (2016-2021)
11.10.5 STORM Therapeutics Recent Development
11.11 Twentyeight-Seven Therapeutics
11.11.1 Twentyeight-Seven Therapeutics Company Details
11.11.2 Twentyeight-Seven Therapeutics Business Overview
11.11.3 Twentyeight-Seven Therapeutics RNA-Targeted Small Molecules Introduction
11.11.4 Twentyeight-Seven Therapeutics Revenue in RNA-Targeted Small Molecules Business (2016-2021)
11.11.5 Twentyeight-Seven Therapeutics Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global RNA-Targeted Small Molecules Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of mRNA Translation Regulation
Table 3. Key Players of RNA Splicing Modification
Table 4. Key Players of Direct RNA Targeting
Table 5. Key Players of Indirect RNA Targeting - Epitranscriptomics
Table 6. Global RNA-Targeted Small Molecules Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global RNA-Targeted Small Molecules Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global RNA-Targeted Small Molecules Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global RNA-Targeted Small Molecules Market Share by Regions (2016-2021)
Table 10. Global RNA-Targeted Small Molecules Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global RNA-Targeted Small Molecules Market Share by Regions (2022-2027)
Table 12. RNA-Targeted Small Molecules Market Trends
Table 13. RNA-Targeted Small Molecules Market Drivers
Table 14. RNA-Targeted Small Molecules Market Challenges
Table 15. RNA-Targeted Small Molecules Market Restraints
Table 16. Global RNA-Targeted Small Molecules Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global RNA-Targeted Small Molecules Market Share by Players (2016-2021)
Table 18. Global Top RNA-Targeted Small Molecules Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in RNA-Targeted Small Molecules as of 2020)
Table 19. Ranking of Global Top RNA-Targeted Small Molecules Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by RNA-Targeted Small Molecules Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players RNA-Targeted Small Molecules Product Solution and Service
Table 23. Date of Enter into RNA-Targeted Small Molecules Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global RNA-Targeted Small Molecules Market Size by Type (2016-2021) (US$ Million)
Table 26. Global RNA-Targeted Small Molecules Revenue Market Share by Type (2016-2021)
Table 27. Global RNA-Targeted Small Molecules Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global RNA-Targeted Small Molecules Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global RNA-Targeted Small Molecules Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global RNA-Targeted Small Molecules Revenue Market Share by Application (2016-2021)
Table 31. Global RNA-Targeted Small Molecules Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global RNA-Targeted Small Molecules Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America RNA-Targeted Small Molecules Market Size by Type (2016-2021) (US$ Million)
Table 34. North America RNA-Targeted Small Molecules Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America RNA-Targeted Small Molecules Market Size by Application (2016-2021) (US$ Million)
Table 36. North America RNA-Targeted Small Molecules Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America RNA-Targeted Small Molecules Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America RNA-Targeted Small Molecules Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe RNA-Targeted Small Molecules Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe RNA-Targeted Small Molecules Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe RNA-Targeted Small Molecules Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe RNA-Targeted Small Molecules Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe RNA-Targeted Small Molecules Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe RNA-Targeted Small Molecules Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific RNA-Targeted Small Molecules Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific RNA-Targeted Small Molecules Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific RNA-Targeted Small Molecules Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific RNA-Targeted Small Molecules Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific RNA-Targeted Small Molecules Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific RNA-Targeted Small Molecules Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America RNA-Targeted Small Molecules Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America RNA-Targeted Small Molecules Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America RNA-Targeted Small Molecules Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America RNA-Targeted Small Molecules Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America RNA-Targeted Small Molecules Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America RNA-Targeted Small Molecules Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa RNA-Targeted Small Molecules Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa RNA-Targeted Small Molecules Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa RNA-Targeted Small Molecules Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa RNA-Targeted Small Molecules Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa RNA-Targeted Small Molecules Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa RNA-Targeted Small Molecules Market Size by Country (2022-2027) & (US$ Million)
Table 63. Accent Therapeutics Company Details
Table 64. Accent Therapeutics Business Overview
Table 65. Accent Therapeutics RNA-Targeted Small Molecules Product
Table 66. Accent Therapeutics Revenue in RNA-Targeted Small Molecules Business (2016-2021) & (US$ Million)
Table 67. Accent Therapeutics Recent Development
Table 68. Anima Biotech Inc. Company Details
Table 69. Anima Biotech Inc. Business Overview
Table 70. Anima Biotech Inc. RNA-Targeted Small Molecules Product
Table 71. Anima Biotech Inc. Revenue in RNA-Targeted Small Molecules Business (2016-2021) & (US$ Million)
Table 72. Anima Biotech Inc. Recent Development
Table 73. Arrakis Pharmaceuticals Company Details
Table 74. Arrakis Pharmaceuticals Business Overview
Table 75. Arrakis Pharmaceuticals RNA-Targeted Small Molecules Product
Table 76. Arrakis Pharmaceuticals Revenue in RNA-Targeted Small Molecules Business (2016-2021) & (US$ Million)
Table 77. Arrakis Pharmaceuticals Recent Development
Table 78. Epics Therapeutics Company Details
Table 79. Epics Therapeutics Business Overview
Table 80. Epics Therapeutics RNA-Targeted Small Molecules Product
Table 81. Epics Therapeutics Revenue in RNA-Targeted Small Molecules Business (2016-2021) & (US$ Million)
Table 82. Epics Therapeutics Recent Development
Table 83. Expansion Therapeutics Company Details
Table 84. Expansion Therapeutics Business Overview
Table 85. Expansion Therapeutics RNA-Targeted Small Molecules Product
Table 86. Expansion Therapeutics Revenue in RNA-Targeted Small Molecules Business (2016-2021) & (US$ Million)
Table 87. Expansion Therapeutics Recent Development
Table 88. Gotham Therapeutics Company Details
Table 89. Gotham Therapeutics Business Overview
Table 90. Gotham Therapeutics RNA-Targeted Small Molecules Product
Table 91. Gotham Therapeutics Revenue in RNA-Targeted Small Molecules Business (2016-2021) & (US$ Million)
Table 92. Gotham Therapeutics Recent Development
Table 93. H3 Biomedicine Company Details
Table 94. H3 Biomedicine Business Overview
Table 95. H3 Biomedicine RNA-Targeted Small Molecules Product
Table 96. H3 Biomedicine Revenue in RNA-Targeted Small Molecules Business (2016-2021) & (US$ Million)
Table 97. H3 Biomedicine Recent Development
Table 98. Ribometrix Company Details
Table 99. Ribometrix Business Overview
Table 100. Ribometrix Revenue in RNA-Targeted Small Molecules Business (2016-2021) & (US$ Million)
Table 101. Ribometrix Recent Development
Table 102. Skyhawk Therapeutics Company Details
Table 103. Skyhawk Therapeutics Business Overview
Table 104. Skyhawk Therapeutics RNA-Targeted Small Molecules Product
Table 105. Skyhawk Therapeutics Revenue in RNA-Targeted Small Molecules Business (2016-2021) & (US$ Million)
Table 106. Skyhawk Therapeutics Recent Development
Table 107. STORM Therapeutics Company Details
Table 108. STORM Therapeutics Business Overview
Table 109. STORM Therapeutics RNA-Targeted Small Molecules Product
Table 110. STORM Therapeutics Revenue in RNA-Targeted Small Molecules Business (2016-2021) & (US$ Million)
Table 111. STORM Therapeutics Recent Development
Table 112. Twentyeight-Seven Therapeutics Company Details
Table 113. Twentyeight-Seven Therapeutics Business Overview
Table 114. Twentyeight-Seven Therapeutics RNA-Targeted Small Molecules Product
Table 115. Twentyeight-Seven Therapeutics Revenue in RNA-Targeted Small Molecules Business (2016-2021) & (US$ Million)
Table 116. Twentyeight-Seven Therapeutics Recent Development
Table 117. Research Programs/Design for This Report
Table 118. Key Data Information from Secondary Sources
Table 119. Key Data Information from Primary Sources
List of Figures
Figure 1. Global RNA-Targeted Small Molecules Market Share by Type: 2020 VS 2027
Figure 2. mRNA Translation Regulation Features
Figure 3. RNA Splicing Modification Features
Figure 4. Direct RNA Targeting Features
Figure 5. Indirect RNA Targeting - Epitranscriptomics Features
Figure 6. Global RNA-Targeted Small Molecules Market Share by Application: 2020 VS 2027
Figure 7. Hospitals Case Studies
Figure 8. Laboratories Case Studies
Figure 9. Phamacy Case Studies
Figure 10. RNA-Targeted Small Molecules Report Years Considered
Figure 11. Global RNA-Targeted Small Molecules Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global RNA-Targeted Small Molecules Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global RNA-Targeted Small Molecules Market Share by Regions: 2020 VS 2027
Figure 14. Global RNA-Targeted Small Molecules Market Share by Regions (2022-2027)
Figure 15. Global RNA-Targeted Small Molecules Market Share by Players in 2020
Figure 16. Global Top RNA-Targeted Small Molecules Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in RNA-Targeted Small Molecules as of 2020
Figure 17. The Top 10 and 5 Players Market Share by RNA-Targeted Small Molecules Revenue in 2020
Figure 18. Global RNA-Targeted Small Molecules Revenue Market Share by Type (2016-2021)
Figure 19. Global RNA-Targeted Small Molecules Revenue Market Share by Type (2022-2027)
Figure 20. North America RNA-Targeted Small Molecules Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America RNA-Targeted Small Molecules Market Share by Type (2016-2027)
Figure 22. North America RNA-Targeted Small Molecules Market Share by Application (2016-2027)
Figure 23. North America RNA-Targeted Small Molecules Market Share by Country (2016-2027)
Figure 24. United States RNA-Targeted Small Molecules Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada RNA-Targeted Small Molecules Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe RNA-Targeted Small Molecules Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe RNA-Targeted Small Molecules Market Share by Type (2016-2027)
Figure 28. Europe RNA-Targeted Small Molecules Market Share by Application (2016-2027)
Figure 29. Europe RNA-Targeted Small Molecules Market Share by Country (2016-2027)
Figure 30. Germany RNA-Targeted Small Molecules Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France RNA-Targeted Small Molecules Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. RNA-Targeted Small Molecules Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy RNA-Targeted Small Molecules Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia RNA-Targeted Small Molecules Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic RNA-Targeted Small Molecules Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific RNA-Targeted Small Molecules Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific RNA-Targeted Small Molecules Market Share by Type (2016-2027)
Figure 38. Asia-Pacific RNA-Targeted Small Molecules Market Share by Application (2016-2027)
Figure 39. Asia-Pacific RNA-Targeted Small Molecules Market Share by Region (2016-2027)
Figure 40. China RNA-Targeted Small Molecules Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan RNA-Targeted Small Molecules Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea RNA-Targeted Small Molecules Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia RNA-Targeted Small Molecules Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India RNA-Targeted Small Molecules Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia RNA-Targeted Small Molecules Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America RNA-Targeted Small Molecules Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America RNA-Targeted Small Molecules Market Share by Type (2016-2027)
Figure 48. Latin America RNA-Targeted Small Molecules Market Share by Application (2016-2027)
Figure 49. Latin America RNA-Targeted Small Molecules Market Share by Country (2016-2027)
Figure 50. Mexico RNA-Targeted Small Molecules Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil RNA-Targeted Small Molecules Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa RNA-Targeted Small Molecules Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa RNA-Targeted Small Molecules Market Share by Type (2016-2027)
Figure 54. Middle East & Africa RNA-Targeted Small Molecules Market Share by Application (2016-2027)
Figure 55. Middle East & Africa RNA-Targeted Small Molecules Market Share by Country (2016-2027)
Figure 56. Turkey RNA-Targeted Small Molecules Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia RNA-Targeted Small Molecules Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE RNA-Targeted Small Molecules Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Accent Therapeutics Revenue Growth Rate in RNA-Targeted Small Molecules Business (2016-2021)
Figure 60. Anima Biotech Inc. Revenue Growth Rate in RNA-Targeted Small Molecules Business (2016-2021)
Figure 61. Arrakis Pharmaceuticals Revenue Growth Rate in RNA-Targeted Small Molecules Business (2016-2021)
Figure 62. Epics Therapeutics Revenue Growth Rate in RNA-Targeted Small Molecules Business (2016-2021)
Figure 63. Expansion Therapeutics Revenue Growth Rate in RNA-Targeted Small Molecules Business (2016-2021)
Figure 64. Gotham Therapeutics Revenue Growth Rate in RNA-Targeted Small Molecules Business (2016-2021)
Figure 65. H3 Biomedicine Revenue Growth Rate in RNA-Targeted Small Molecules Business (2016-2021)
Figure 66. Ribometrix Revenue Growth Rate in RNA-Targeted Small Molecules Business (2016-2021)
Figure 67. Skyhawk Therapeutics Revenue Growth Rate in RNA-Targeted Small Molecules Business (2016-2021)
Figure 68. STORM Therapeutics Revenue Growth Rate in RNA-Targeted Small Molecules Business (2016-2021)
Figure 69. Twentyeight-Seven Therapeutics Revenue Growth Rate in RNA-Targeted Small Molecules Business (2016-2021)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed

以下、関連資料のご紹介

世界の合成小分子市場規模・現状・予測（2021年-2027年）

Global Synthetic Small Molecules Market Size, Status and Forecast 2021-2027
QFJ1-2430 2021年6月 95Pages
QYResearch社発行の本調査レポートでは、合成小分子の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（小分子阻害剤、小分子従来薬、その他）、用途別市場規模（心血管、腫瘍、糖尿病、免疫疾患、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジ...

世界の内在性カンナビノイドシステム標的治療市場規模・現状・予測（2021年-2027年）

Global Endocannabinoid System Targeted Therapeutics Market Size, Status and Forecast 2021-2027
QFJ1-4185 2021年6月 109Pages
QYResearch社発行の本調査レポートでは、内在性カンナビノイドシステム標的治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口、吸入、その他）、用途別市場規模（自己免疫疾患、遺伝性疾患、神経疾患、疼痛性疾患）、主要地域別市場規模（北米、ア...

世界の小分子標的治療市場規模・現状・予測（2021年-2027年）

Global Small Molecule Targeted Therapy Market Size, Status and Forecast 2021-2027
QFJ1-4876 2021年6月 107Pages
QYResearch社発行の本調査レポートでは、小分子標的治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（TKI、マルチターゲット阻害剤、その他）、用途別市場規模（肝臓がん、結腸直腸がん、肺がん、胃がん、乳がん、食道がん、その他）、主要地域別市...

世界の小分子標的抗がん剤市場規模・現状・予測（2021年-2027年）

Global Small Molecule Targeted Anti-cancer Drug Market Size, Status and Forecast 2021-2027
QFJ1-6013 2021年6月 108Pages
QYResearch社発行の本調査レポートでは、小分子標的抗がん剤の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（EGFR、ALK、Bcr-Abl、その他）、用途別市場規模（肝臓がん、結腸直腸がん、肺がん、胃がん、乳がん、食道がん、その他）、主要地...

世界の注射式標的治療市場規模・現状・予測（2021年-2027年）

Global Injectable Targeted Therapy Market Size, Status and Forecast 2021-2027
QFJ1-4374 2021年6月 109Pages
QYResearch社発行の本調査レポートでは、注射式標的治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（モノクローナル抗体、小分子、免疫毒素、その他）、用途別市場規模（病院、在宅医療、専門クリニック、その他）、主要地域別市場規模（北米、アメリ...

世界のネオアンチゲン標的療法市場規模・現状・予測（2021年-2027年）

Global Neoantigen Targeted Therapies Market Size, Status and Forecast 2021-2027
QFJ1-5264 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、ネオアンチゲン標的療法の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（単剤療法、併用療法）、用途別市場規模（医療研究機関、病院・クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、...

世界の標的化デリバリードラッグ市場規模・現状・予測（2021年-2027年）

Global Targeted Delivery Drugs Market Size, Status and Forecast 2021-2027
QFJ1-4934 2021年6月 107Pages
QYResearch社発行の本調査レポートでは、標的化デリバリードラッグの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（眼用ドラッグデリバリー、肺のドラッグデリバリー、薬剤溶出ステント、その他）、用途別市場規模（病院、診療所、その他）、主要地域別市...

世界のB細胞成熟抗原（BCMA）標的療法市場規模・現状・予測（2021年-2027年）

Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size, Status and Forecast 2021-2027
QFJ1-3893 2021年6月 109Pages
QYResearch社発行の本調査レポートでは、B細胞成熟抗原（BCMA）標的療法の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（二重特異性抗体、抗体薬物複合体、キメラ抗原受容体T細胞）、用途別市場規模（肝臓がん、呼吸器がん、脳腫瘍、その他）、主要...

世界の低分子干渉RNA（siRNA）治療薬市場規模・現状・予測（2021年-2027年）

Global Small Interfering RNA (siRNA) Therapeutics Market Size, Status and Forecast 2021-2027
QFJ1-4874 2021年6月 107Pages
QYResearch社発行の本調査レポートでは、低分子干渉RNA（siRNA）治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（リポソームベース全身療法、ナノ粒子ベース全身療法、その他）、用途別市場規模（病院、研究機関、製薬・バイオテクノロジー...

世界の未分化大細胞リンパ腫治療薬市場規模・現状・予測（2021年-2027年）

Global Anaplastic Large Cell Lymphoma Therapeutics Market Size, Status and Forecast 2021-2027
QFJ1-3799 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、未分化大細胞リンパ腫治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（AKR-303、AZD-3463、ブレンツキシマブベドチン、CEP-28122、その他）、用途別市場規模（入院患者、外来患者）...

世界の合成小分子市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Synthetic Small Molecules Market The global Synthetic Small Molecules market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, th…
世界の小分子標的治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Small Molecule Targeted Therapy Market The global Small Molecule Targeted Therapy market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data i…
世界の小分子標的抗がん剤市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Small Molecule Targeted Anti-cancer Drug Market The global Small Molecule Targeted Anti-cancer Drug market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analys…
世界の注射式標的治療市場規模・現状・予測（2021年-2027年） It is at the cellular and molecular level, designed for the treatment of well-defined carcinogenic sites, and designing corresponding therapeutic drugs. When drugs enter the body, they will specifically select carcinogenic sites to combine and act, causing tumor cells to die specifically, without Wi…
世界の標的バイオマーカー市場規模・現状・予測（2021年-2027年） Targeted Biomarker refers to biochemical indicators that can mark changes or possible changes in the structure or function of systems, organs, tissues, cells, and subcellular cells, and has a wide range of uses. Targeted Biomarker can be used to diagnose diseases, determine stage of disease, or to e…